This award will fund clinical, basic, translational, and population health projects that seek to better understand the pathobiology and clinical implications of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral infection that leads to the morbidity and mortality seen with COVID-19 : a new understanding of the basic biology of respiratory viruses that could lead to better treatment and prevention; development of novel therapeutics and vaccines; understanding host factors that alter response to these infections; understanding individual, regional, or social factors increasing or decreasing community spread of COVID-19 and other respiratory viruses; and case tracking and epidemiological approaches. Grants are up to $200,000 over two years; proposals are due by May 30, 2020.
Subscribe to the UArizona Impact in Action newsletter to receive featured stories and event info to connect you with UArizona's research, innovation, entrepreneurial ventures, and societal impacts.